InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Sandeep Phadnis — insider filings · 20 reports

← Executives ★ Sign in to follow

SP

Sandeep Phadnis

ININ·SEBI (PIT + SAST)

JB Chemicals & Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Sandeep Phadnis. Director active across 1 companies, notably JB Chemicals & Pharmaceuticals Limited. Aggregated, 20 disclosures have been published. The latest transaction was disclosed on 12 June 2025 — Sale. Regulator: SEBI (PIT + SAST). All data is free.

Declarations20 total

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€17,6701,000 shares@ €17.6703

Equity Shares

SEBI:ba4a7b9e8316aaf6231c50a978b35dade7f9d7b7·12 Jun 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€18,6271,000 shares@ €18.6268

Equity Shares

SEBI:88fa7d1dad660565c6697b5f5f8005aa073efe0b·13 Feb 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€43,0842,070 shares@ €20.8135

Equity Shares

SEBI:486bf84607207e8730a285a2b9ecab7cb95208f6·30 Dec 2024

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€43,0842,070 shares@ €20.8135

Equity Shares

SEBI:1f5f09de51b024f96f90ccde2a44a495b9300ee1·30 Dec 2024

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€63,0053,070 shares@ €20.5228

Equity Shares

SEBI:33dd4e2fd36cbd4bb89ab9caab1a152e0f3e885a·23 Dec 2024

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€63,8783,070 shares@ €20.8072

Equity Shares

SEBI:aa7d97d88f0b353179aac79ed894aa7b482cb9f0·18 Dec 2024

Ideal exit: 14 Sept 2025 (T+270)

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€51,3952,500 shares@ €20.5581

Equity Shares

SEBI:c0e661f177e14d4119dd656d8c9bb9b5bf94ea9d·12 Dec 2024

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€51,3952,500 shares@ €20.5581

Equity Shares

SEBI:b6c8d096e7cf1cc5524b66577eaa09b10eb5eb8d·12 Dec 2024

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€51,1322,500 shares@ €20.4528

Equity Shares

SEBI:7082a88e6c5d2aa7ca6ceb8ec9c890f0c2a7ad24·12 Dec 2024

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€49,1522,500 shares@ €19.661

Equity Shares

SEBI:e6ddd77678cde4db42ab899e75e5493d7197bb24·6 Dec 2024

Ideal exit: 2 Sept 2025 (T+270)

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€34,5741,860 shares@ €18.588

Equity Shares

SEBI:9166e9964e8421e17f51ee940fb45946a02904b7·12 Feb 2024

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€34,8361,860 shares@ €18.7292

Equity Shares

SEBI:57542cf19904babf6263cbabe30d86e73360f831·5 Feb 2024

Ideal exit: 1 Nov 2024 (T+270)

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€28,496930 shares@ €30.6405

Equity Shares

SEBI:bb1c9fd9bc82fd144f70e648428020b92f6514ff·23 Aug 2023

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€28,496930 shares@ €30.6405

Equity Shares

SEBI:bdbbfa1ebb046cdf70f6fd0b6836ee4d83275ae4·23 Aug 2023

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€27,599930 shares@ €29.676

Equity Shares

SEBI:af159d98e05e012062d8ced857fbdc92c2539c4c·22 Aug 2023

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€27,064930 shares@ €29.1016

Equity Shares

SEBI:5950762b90025fb5dac0c40e9a2c8ddeec56fe91·13 Aug 2023

Ideal exit: 9 May 2024 (T+270)

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€11,881497 shares@ €23.9058

Equity Shares

SEBI:97bfaab16ea21c8e3c4d7b338145b1604bb6ceb5·31 May 2023

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€11,881497 shares@ €23.9058

Equity Shares

SEBI:876f39a87832cbef120d6805ebbe523b82321f0f·31 May 2023

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€20,376920 shares@ €22.1473

Equity Shares

SEBI:5c9615abfb5a29fa72f2bb1dad506f1a0211af96·28 Dec 2022

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sandeep Phadnis

€20,973920 shares@ €22.7966

Equity Shares

SEBI:6ceb4f52b75afb5e84a56950953281ca80f2768e·20 Dec 2022

Ideal exit: 16 Sept 2023 (T+270)

20 of 20 declarations